Hepatitis B virus in pregnancy

Clinical Liver Disease

Volumn 2, Issue 1, 2013, Pages 29-33

  Tran, Tram T ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M; INTERFERON; LAMIVUDINE; PEGINTERFERON; PLACEBO; TELBIVUDINE; TENOFOVIR; VIRUS DNA; ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ABSENCE OF SIDE EFFECTS; ANTIGEN DETECTION; BREAST FEEDING; CESAREAN SECTION; CHILDBIRTH; DRUG SAFETY; FAMILY PLANNING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMINENT ABORTION; IMMUNOLOGICAL TOLERANCE; INFECTION PREVENTION; META ANALYSIS (TOPIC); PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; TREATMENT DURATION; VAGINAL DELIVERY; VIRUS LOAD; VIRUS TRANSMISSION; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL (TOPIC); DISEASE TRANSMISSION; DRUG APPROVAL; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; INFECTION RATE; INFECTION RISK; NONHUMAN; PERINATAL PERIOD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; VACCINATION; VERTICAL TRANSMISSION; VIREMIA; VIRUS MUTATION; VIRUS TITRATION;

EID: 84888279154     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.159     Document Type: Review

References (23)

1. World Health Organization. Hepatitis B: fact sheet no. 204. http://who.int/mediacentre/factsheets/fs204/en/index.html. Accessed December 1, 2012.
2. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign born persons living in the United States by country of origin. Hepatology 2012; 56: 422-433.
3. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, 292: 771-774.
4. Lee SD, Lo KJ, Tsai YT, Wu JC. Maternal hepatitis B virus DNA in mother-infant transmission. Lancet 1989; 1: 719.
5. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997; 176: 1360-1365.
6. Karthigesu VD, Allison LM, Ferguson M, Howard CR. A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant. J Med Virol 1999; 58: 346-352.
7. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111: 877-881.
8. Lazizi Y, Badur S, Perk Y, Ilter O, Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997; 15: 1095-1100.
9. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-26.
10. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111: 877-881.
11. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001; 184: 1514-1518.
12. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 1418-1423.
13. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 109: 489-492.
14. Zou H, Chen Y, Duan Z et al. A retrospective study for clinical outcome of caesarean section on perinatal transmission of hepatitis B virus in infants born to HBeAg positive mothers with chronic hepatitis. Hepatology 2010; 52: 235A.
15. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, et al. Role of caesarean section in prevention of mother-infant transmission of hepatitis B. Lancet 1988; 2: 833-834.
16. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99: 1049-1052.
17. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 1-36.
18. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103.
19. Han L, Zhang H-W, Xie J-X, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17: 4321-4333.
20. Han G-R, Cao M-K, Zhao W, Jiang HX, Wang CM, Bai SF, et al. A prospective and open label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatology 2011; 55: 1215-1221.
21. The Antiretroviral Pregancy Registry Interim Report for 1 January 1989 through 31 July 2011. http://www.apregistry.com. Accessed December 1, 2012.
22. Ter Borg MJ, Leemans WF, de Man RA, Janssen HLA. Exacerbation of chronic hepatitis B infection after delivery. J Vir Hepat 2008; 15: 37-41.
23. Singhal A, Kanagala R, Jalil S, Wright HI, Kohli V. Chronic HBV with pregnancy: reactivation flare causing fulminant hepatic failure. Ann Hepatol 2011; 10: 233-236.